ARK Genomic Revolution ETF (ARKG) est une société cotée en bourse dans le Services Financiers secteur, opérant dans le Asset Management secteur d'activité.
ARKG a date d'introduction en bourse 2014-10-31, cotée sur le Chicago Board Option, une capitalisation boursière de $1.18B.
ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors that are relevant to the Fund’s investment theme of the genomics revolution.
